Product Description

Ibruxen Tablets 140mg contains Ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor used to treat certain blood cancers, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), Waldenström macroglobulinemia (WM), and chronic graft-versus-host disease (cGVHD).

Product Overview

Product Name: Ibruxen Tablets 140mg

Generic Name: Ibrutinib

Strength: 140mg

Form: Tablets

Pack Size: As per manufacturer packaging

Used For: Treatment of selected blood cancers and chronic graft-versus-host disease

Prescription Required: Yes

Ingredients & How They Work

Each tablet contains Ibrutinib 140mg, which blocks Bruton's tyrosine kinase (BTK), slowing the growth and survival of abnormal B-cells responsible for certain blood cancers.

Key Benefits

• Treats chronic lymphocytic leukemia (CLL)
• Used in mantle cell lymphoma (MCL)
• Effective in Waldenström macroglobulinemia (WM)
• Helps manage chronic graft-versus-host disease
• Targeted oral cancer therapy

How to Use

Take exactly as prescribed by your oncologist. Swallow the tablet whole with water at the same time each day. Do not crush, chew, or break the tablet.

Side Effects & Precautions

Possible Side Effects

• Diarrhea
• Fatigue
• Bruising
• Bleeding
• Muscle and joint pain

Precautions

• Regular blood tests may be required.
• Inform your doctor if you experience unusual bleeding or signs of infection.
• Avoid grapefruit and Seville oranges during treatment.
• Use only under specialist supervision.

Storage Instructions

Store below 30°C in a cool, dry place away from moisture and direct sunlight.